Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed / Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05060627
What this trial is testing

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

Who this might be right for
Relapsed Multiple Myeloma
PETHEMA Foundation 60
Early research (Phase 1)Ended earlyNCT03755154
What this trial is testing

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Non-Hodgkin LymphomaRelapsed or Refractory Multiple Myeloma+1 more
Institut de Recherches Internationales Servier 60
Testing effectiveness (Phase 2)Ended earlyNCT00790842
What this trial is testing

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
PrECOG, LLC. 63
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07518186
What this trial is testing

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 700
Testing effectiveness (Phase 2)Study completedNCT00229203
What this trial is testing

Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
PharmaMar 51
Not applicableUnknownNCT03380039
What this trial is testing

Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT04083534
What this trial is testing

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Regeneron Pharmaceuticals 43
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Not applicableNot Yet RecruitingNCT07564128
What this trial is testing

Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy

Who this might be right for
Multiple Mieloma
Gruppo Italiano Malattie EMatologiche dell'Adulto 50
Large-scale testing (Phase 3)Study completedNCT00003805
What this trial is testing

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

Who this might be right for
Bone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more
European Organisation for Research and Treatment of Cancer - EORTC 859
Early research (Phase 1)Study completedNCT03338972
What this trial is testing

Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT06105554
What this trial is testing

Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 36
Very early researchLooking for participantsNCT07249073
What this trial is testing

CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Large-scale testing (Phase 3)Looking for participantsNCT06508983
What this trial is testing

A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Hangzhou Sumgen Biotech Co., Ltd. 360
Early research (Phase 1)Study completedNCT01533194
What this trial is testing

Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Light Chain Deposition DiseaseRefractory Plasma Cell Myeloma
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT04721002
What this trial is testing

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma (MM)
AbbVie 514
Early research (Phase 1)Looking for participantsNCT05862012
What this trial is testing

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA 200
Early research (Phase 1)Ended earlyNCT04892264
What this trial is testing

Belantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 5
Large-scale testing (Phase 3)Looking for participantsNCT07258511
What this trial is testing

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 400
Next Page